Novel blood return system cuts blood loss by 97% in pulmonary embolism procedure
The first comparative analysis from the ENGULF (A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device For the Treatment of Pulmonary Embolism) trial shows that using blood return during continuous aspiration thrombectomy dramatically reduces blood loss by 97%, while maint
ORIGINAL SOURCE →via Medical Xpress
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · conflict
- [CONFLICT] Intermodal Asia
- [CONFLICT] [Comment] Antibody-based malaria prevention in an intense perennial transmission setting
- [CONFLICT] [World Report] New Government aims to revitalise health in Hungary
- [CONFLICT] [Perspectives] Caring for the caregivers
- [CONFLICT] [Correspondence] Systematic health destruction in Iran by Operation Epic Fury
- [CONFLICT] [Correspondence] Microbiological governance and the Lancet Commission on Ukraine